CreditReports.dk
HomeScreen companies

1Point Pharma ApS Financials, key figures and credit report

CVR number: 44804425 Established 2024 Industry: 46 Wholesale trade
Company contact details
Christians Brygge 28, 1559 København V info@1pointpharma.com tel: 27808099 www.1pointpharma.com
Gross profit -1 314.0 kDKK FY 2025 -264.1% vs 2024
EBIT -1 874.6 kDKK FY 2025 -146.6% vs 2024
Net debt 579.2 kDKK FY 2025 +159.7% vs 2024
Quick ratio 12.3 FY 2025

Company information

Official name
1Point Pharma ApS
Personnel
5 persons
Established
2024
Company form
Private limited company
Industry

Data sources and methodology

The information about 1Point Pharma ApS combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.

Open the 2025 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About 1Point Pharma ApS

1Point Pharma ApS (CVR number: 4480442-5) is a company from KØBENHAVN. The company recorded a gross profit of -1314 kDKK in 2025. The operating profit was -1874.6 kDKK, while net earnings were -1484.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was -70.3 %, which can be considered poor and Return on Equity (ROE) was -116.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 27 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. 1Point Pharma ApS's liquidity measured by quick ratio was 12.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2024
2025
Volume
Net sales
Gross profit- 360.89-1 313.95
EBIT- 760.17-1 874.62
Net earnings- 592.81-1 484.86
Shareholders equity total1 617.32932.46
Balance sheet total (assets)1 885.683 450.75
Net debt- 969.87579.22
Profitability
EBIT-%
ROA-40.3 %-70.3 %
ROE-36.7 %- 116.5 %
ROI-45.7 %-51.9 %
Economic value added (EVA)- 593.09-1 546.31
Solvency
Equity ratio85.8 %27.0 %
Gearing2.7 %250.3 %
Relative net indebtedness %
Liquidity
Quick ratio12.3
Current ratio15.0
Cash and cash equivalents1 014.061 755.07
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2025
-70.3%
Rating 0/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2025
27.0%
Rating 24/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of 1Point Pharma ApS before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated